Literature DB >> 26744445

Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations.

T T Winton-Brown1, A Ting2, R Mocellin1, M Walterfang, D Velakoulis3, F Gaillard4.   

Abstract

Visual hallucinations are relatively uncommon presentations in medical and psychiatric clinics, where they are generally regarded as a marker of possible underlying "organic" brain disease. Thus, patients with visual hallucinations are often referred for imaging of the brain. This article presents a pragmatic approach for the radiologist reviewing such imaging. Because conditions that can present with visual hallucinations are legion, a familiarity with the features of the hallucinations themselves, which can serve as clues to the underlying cause, can be helpful in interpreting such cases. We consider the nature of visual hallucinations and the mechanisms underlying their formation. We then provide a framework to guide the search for their cause, first in terms of focal lesions along the visual pathway and then global conditions affecting >1 region.
© 2016 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 26744445      PMCID: PMC7960303          DOI: 10.3174/ajnr.A4636

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  68 in total

Review 1.  Migraine--current understanding and treatment.

Authors:  Peter J Goadsby; Richard B Lipton; Michel D Ferrari
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

2.  Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study.

Authors:  Maria A Rocca; Antonia Ceccarelli; Andrea Falini; Bruno Colombo; Paola Tortorella; Luca Bernasconi; Giancarlo Comi; Giuseppe Scotti; Massimo Filippi
Journal:  Stroke       Date:  2006-05-25       Impact factor: 7.914

Review 3.  Pharmacological treatment of Parkinson disease: a review.

Authors:  Barbara S Connolly; Anthony E Lang
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

4.  Visual hallucinations in posterior cortical atrophy.

Authors:  Keith A Josephs; Jennifer L Whitwell; Bradley F Boeve; David S Knopman; David F Tang-Wai; Daniel A Drubach; Clifford R Jack; Ronald C Petersen
Journal:  Arch Neurol       Date:  2006-10

5.  Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences.

Authors:  K Kallenberg; W J Schulz-Schaeffer; U Jastrow; S Poser; B Meissner; H J Tschampa; I Zerr; M Knauth
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

6.  Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways.

Authors:  M S Vaphiades; G G Celesia; M G Brigell
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

7.  The occipital white matter lesions in Alzheimer's disease patients with visual hallucinations.

Authors:  Shu-Han Lin; Chin-Yin Yu; Ming-Chyi Pai
Journal:  Clin Imaging       Date:  2006 Nov-Dec       Impact factor: 1.605

8.  Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system.

Authors:  L H Calabrese; L A Gragg; A J Furlan
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

9.  MR imaging of Creutzfeldt-Jakob disease.

Authors:  M Finkenstaedt; A Szudra; I Zerr; S Poser; J H Hise; J M Stoebner; T Weber
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

Review 10.  Clinical aspects and pathophysiology of narcolepsy.

Authors:  Yves Dauvilliers; Michel Billiard; Jacques Montplaisir
Journal:  Clin Neurophysiol       Date:  2003-11       Impact factor: 3.708

View more
  2 in total

Review 1.  Psychosis Associated with Acquired Porencephaly-Cause or Incidental Finding? Case Report and Review of Literature.

Authors:  Maria Gabriela Puiu; Vlad Dionisie; Alexandru Cristian Filip; Mirela Manea
Journal:  Medicina (Kaunas)       Date:  2022-04-24       Impact factor: 2.948

Review 2.  Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.

Authors:  Mark T Bolinger; David A Antonetti
Journal:  Int J Mol Sci       Date:  2016-09-07       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.